menu
    • menu

    Company profile for Exousia Pro

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Exousia Pro is a clinical-stage biotech pioneering exosome-based therapies to revolutionize oncology treatment. Leveraging the natural therapeutic potential of exosomes, we develop targeted, innovative solutions to combat cancer with enhanced precision and reduced side effects. Our cutting-edge research harnesses exosomes' unique properties for drug delivery, immune modulation, and diagnostics. Committed to transforming patien...
    Exousia Pro is a clinical-stage biotech pioneering exosome-based therapies to revolutionize oncology treatment. Leveraging the natural therapeutic potential of exosomes, we develop targeted, innovative solutions to combat cancer with enhanced precision and reduced side effects. Our cutting-edge research harnesses exosomes' unique properties for drug delivery, immune modulation, and diagnostics. Committed to transforming patient outcomes, we bridge groundbreaking science with clinical applications to unlock new frontiers in cancer therapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Exousia ProUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7901 4th Street N #23494 St. Petersburg, FL 33702
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://exousiapro.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exousia Signs Strategic LOI for Nutraceutical Commercialization
    Exousia Signs Strategic LOI for Nutraceutical Commercialization

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/exousia-pro-inc-announces-executed-loi-for-strategic-acquisition-of-high-revenue-telehealth-platfo

    PHARMIWEB
    11 Dec 2025
    Share Share
    Exousia Pro Revolutionizes Nutraceuticals With Launch Of Maxasome
    Exousia Pro Revolutionizes Nutraceuticals With Launch Of Maxasome

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/exousia-pro-inc-revolutionizes-nutraceuticals-with-launch-of-maxasome-tm-the-first-all-natural

    PHARMIWEB
    05 Dec 2025
    Share Share
    Exousia Pro Acquires Controlling Stake In Lamy In All-Stock Deal
    Exousia Pro Acquires Controlling Stake In Lamy In All-Stock Deal

    17 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-17/exousia-pro-initiates-strategic-realignment-acquires-controlling-stake-in-sec-reporter-lamy-lmmy

    PHARMIWEB
    17 Nov 2025
    Share Share
    Exousia Pro Announces Breakthrough In Exosome-Based Delivery
    Exousia Pro Announces Breakthrough In Exosome-Based Delivery

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/exousia-pro-announces-breakthrough-in-exosome-based-delivery

    PHARMIWEB
    04 Nov 2025
    Share Share
    Exousia Pro Receives FDA Orphan Drug Designation
    Exousia Pro Receives FDA Orphan Drug Designation

    28 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-28/exousia-pro-is-excited-to-announce-that-it-has-received-orphan-drug-designation-from-the-fda

    PHARMIWEB
    28 Oct 2025
    Share Share
    Exousia Pro Launches Study To Transform Global CBD Edibles
    Exousia Pro Launches Study To Transform Global CBD Edibles

    29 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-29/exousia-pro-announces-groundbreaking-study-to-revolutionize-the-global-edibles-market-with-cbd-loade

    PHARMAWEB
    29 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search